Induction of breast cancer cell apoptosis by novel pyrrolo[2,3- d ]pyrimidine analogs through modulation of the Bax/Bcl-2 ratio
RSC Advances · 2026
DOI: 10.1039/d6ra06870g ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Advances, 2026. Verfasst von Ashkan Khademi und 7 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Shiraz University of Medical Sciences.
Abstract (Originalsprache)
Breast cancer remains one of the most commonly diagnosed malignancies worldwide, and developing novel cytotoxic agents that overcome therapeutic resistance remains a major priority in anticancer drug discovery.
Förderung
- Shiraz University of Medical Sciences
Zitieren
APA
Khademi, A., Sayahi, M. H., Irajie, C., Haghpanah, V., Larijani, B., Saeedi, M., Iraji, A., & Mahdavi, M. (2026). Induction of breast cancer cell apoptosis by novel pyrrolo[2,3- d ]pyrimidine analogs through modulation of the Bax/Bcl-2 ratio. RSC Advances. https://doi.org/10.1039/d6ra06870g
Vancouver
Khademi A, Sayahi MH, Irajie C, Haghpanah V, Larijani B, Saeedi M, et al. Induction of breast cancer cell apoptosis by novel pyrrolo[2,3- d ]pyrimidine analogs through modulation of the Bax/Bcl-2 ratio. RSC Advances. 2026. doi:10.1039/d6ra06870g
BibTeX
@article{Khademi2026,
author = {Khademi, Ashkan and Sayahi, Mohammad Hosein and Irajie, Cambyz and Haghpanah, Vahid and Larijani, Bagher and Saeedi, Mina and Iraji, Aida and Mahdavi, Mohammad},
title = {Induction of breast cancer cell apoptosis by novel pyrrolo[2,3- d ]pyrimidine analogs through modulation of the Bax/Bcl-2 ratio},
journal = {RSC Advances},
year = {2026},
doi = {10.1039/d6ra06870g}
}
EUVIMED